Moreover, HSP60 knockdown in ovarian cancer cells inhibits tumor progression by breaking mitochondrial proteostasis, and inactivating the mTOR pathway (Guo et al., 2019). This evidence concerns the gene HSPD1 and ovarian carcinoma.